Source: Pharmacy Times articles
Research reveals pioglitazone, a diabetes drug, may slow prostate cancer progression, offering new hope for patients with both conditions.
Read More
by MM360 Staff | May 20, 2025 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Research reveals pioglitazone, a diabetes drug, may slow prostate cancer progression, offering new hope for patients with both conditions.
Read More